Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wajih Jawhar
Observed names:
Jawhar, Wajih,
W. Jawhar
Institutions:
Research Institute of the McGill University Health Centre,
McGill University
Observed institutions:
McGill University Health Centre,
Research Institute of the McGill University Health Centre,
McGill University
ORCID:
0000-0002-2724-6401
Observed ORCID:
0000-0002-2724-6401
OpenAlex ID:
A5063226322
Works
62
Awards
3
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis
2020
·
Carol C.L. Chen
, Shriya Deshmukh
, et al.
·
Cell
·
210
PDF
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2020
·
Sima Khazaei
, Nicolas De Jay
, et al.
·
Cancer Discovery
·
79
Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegeneration
2023
·
Sima Khazaei
, Carol C.L. Chen
, et al.
·
Cell
·
72
Aberrant EZHIP expression drives tumorigenesis in osteosarcoma
2025
·
Wajih Jawhar
, Geoffroy Danieau
, et al.
·
Nature Communications
·
13
PDF
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma
2025
·
Augusto Faria Andrade
, Romain Sigaud
, et al.
·
Nature Immunology
·
5
Bioinspired complex cellulose nanorod-architectures: A model for dual-responsive smart carriers
2024
·
Marzieh Heidari Nia
, Livia Garzia
, et al.
·
Carbohydrate Polymers
·
5
HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2024
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
·
Cancer Research
·
5
Association of novel mutation in TRPV4 with familial nonsyndromic craniosynostosis with complete penetrance and variable expressivity
2023
·
Tenzin Gayden
, Gabriel Crevier-Sorbo
, et al.
·
Journal of Neurosurgery Pediatrics
·
3
H3K27M cooperates with ASCL1 to maintain progenitor states and drive gliomagenesis
2026
·
Alan L. Jiao
, Abolfazl Maghrouni
, et al.
·
Nature Communications
PDF
Figure S3 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Figure S5 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Table S6 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Figure S2 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Table S1 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Figure S4 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Table S3 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Table S2 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Table S4 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Table S5 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Figure S1 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2026
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Open-Label Placebo Effects in Reducing Depression Severity Among Adults with Major Depressive Disorder: A Systematic Review and Meta-Analysis of Early Evidence
2026
·
Janet Mercedes Arévalo-Ipanaqué
, Maria Leticia Gobo Silva
, et al.
·
Principles and Practice of Clinical Research Journal
5P PRC2 antagonism drives chemoresistance in SHH medulloblastoma
2026
·
W. Jawhar
, N. Khazaei
, et al.
·
ESMO rare cancers.
PDF
167P IGF/PI3K–mTOR axis and PRRX1-driven stemness cooperate to promote chemoresistance in CIC-DUX4 sarcoma
2026
·
M. Aghababazadeh
, A. Castillo Orozco
, et al.
·
ESMO rare cancers.
Abstract A074 Uncovering chemoresistance mechanisms in CIC-DUX4 sarcoma using a novel xenograft model
2024
·
Masoumeh Aghababazadeh
, Ana Castillo-Orozco
, et al.
·
Cancer Research
Table S1 from HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
2024
·
Ansley Gnanapragasam
, Eftyhios Kirbizakis
, et al.
Show more works
View as search
Works count:
62
Citation count:
393
H-index:
5
I10-index:
4
Year
Topic
Type